Dako A/S is a Denmark-based, world-leading provider of systems for cancer diagnostics. It was founded by the Danish medical doctor Niels Harboe in 1966 and has more than 40 years' experience in the development and production of reagents and antibodies. Hospital and research laboratories worldwide use Dako reagents, instruments and software to make precise diagnoses and determine the most effective treatment of patients suffering from cancer. With more than 1250 employees and a presence in more than 70 countries, Dako covers most of the global pathology markets.

As a world-leading expert Dako continuously challenges and raises the global standards for fast and accurate answers for cancer patients and doctors making vital decisions for treatment. Dako does this through partnership and by linking knowledge, reagents, instruments and software to improve the entire workflow of the pathology laboratories.